IQVIA Formulary Impact Analyzer (FIA) National provides a national view of prescription drug access using lifecycle prescription claims data. The offering tracks claim adjudication among pharmacies, payers, and patients, reporting paid, rejected, and reversed claim outcomes across retail, mail order, and long-term care channels. Delivered through IQVIA SMART Solutions, FIA National provides monthly updates and access to the most recent six years of data, with analysis by product, market, channel, payer, and method of payment.

Designed primarily for pharmaceutical manufacturers, FIA National supports market access, contracting, forecasting, business development, and brand teams. Applications include formulary change analysis, rebate allocation, pull-through efforts, product launch monitoring, and portfolio analytics. FIA National data are not projected to total market volume and are available alongside National Prescription Audit (NPA) new and total prescription measures within SMART Solutions. Rejected and reversed claims require contextual interpretation and should not independently be used to infer payer access failures, patient abandonment, medication adherence, or clinical outcomes.

Download the brochure to explore how lifecycle prescription claims can support a clearer understanding of payer influence, patient behavior, and prescription access in support of contracting, market access and commercial strategies.